Good day. And thank you for standing by Welcome to the Arbutus BioPharma 2024 3rd quarter, financial results and corporate update. (Operator Instructions) I would now like to hand the conference over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback